Innovative use of geofencing technology boosts enrollment at select sites POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced to ...

Innovative use of geofencing technology boosts enrollment at select sites POTOMAC, MD / ACCESSWIRE / January 8, 2025 / (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ...

Patrick and Carol Webb had lived all over the world. Thirty years serving in the army, while Webb was gone, Carol took care ...

For many nursing home residents, a trip to the hospital can be a jarring experience—one that leaves them confused and ...

For many nursing home residents, a trip to the hospital can be a jarring experience -; one that leaves them confused and stressed.

The company recently announced results from two Phase 3 trials of AXS-05 for agitation. ACCORD-2, hit its main goal, but ...

With two earlier trials meeting their primary endpoints, Axsome claimed it has the data to support a filing for FDA approval ...

A new study has demonstrated for the first time how and why music can reduce distress and agitation for people with advanced dementia. Arizona State University and Banner Alzheimer's Institute ...

Axsome Therapeutics shows strong revenue growth with promising pipeline drugs for migraine, fibromyalgia, and narcolepsy.

On Monday, Axsome Therapeutics, Inc. (NASDAQ:AXSM) released data from ACCORD-2, ADVANCE-2, and long-term safety trials AXS-05 ...

Wells Fargo says that while the ADVANCE-2 miss makes the regulatory path less certain, the totality of the data supports approval for Axsome ...